Identification, purification and characterization of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle plasma membrane

Molecular and Cellular Biochemistry

Volumn 258, Issue 1-2, 2004, Pages 73-89

  Das, Sudip ^a   Mandal, Malay ^a   Mandal, Amritlal ^a   Chakraborti, Tapati ^a   Chakraborti, Sajal ^a  

^a UNIVERSITY OF KALYANI   (India)

Author keywords

Matrix metalloproteinase 2; Pulmonary smooth muscle plasma membrane; Tissue inhibitor of metalloproteinase 2

Indexed keywords

1,10 PHENANTHROLINE; ALPHA 2 MACROGLOBULIN; ASPARTIC PROTEINASE INHIBITOR; CALCIUM ION; CALPASTATIN; COLLAGEN TYPE 4; COLLAGEN TYPE 5; CYSTEINE; EDETIC ACID; EGTAZIC ACID; ENZYME PRECURSOR; GELATINASE A; HEPARIN; PLASMIN; POLYCLONAL ANTIBODY; SEPHAROSE; SERINE; THIOL REAGENT; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRYPSIN;

ANIMAL CELL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTERY MUSCLE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PURIFICATION; GEL ELECTROPHORESIS; IMMUNOBLOTTING; MUSCLE FIBER MEMBRANE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PULMONARY ARTERY; TISSUE DISTRIBUTION;

ANIMALS; CATTLE; CELL MEMBRANE; COLLAGEN TYPE IV; COLLAGEN TYPE V; ENZYME ACTIVATION; ENZYME PRECURSORS; GELATIN; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; PHENYLMERCURY COMPOUNDS; PULMONARY ARTERY; SUBSTRATE SPECIFICITY;

BOVINAE;

EID: 1442306577     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000012838.41792.d2     Document Type: Article

References (55)

1. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991
2. Lee AY, Akers KT, Collier M, Li L, Eisen AZ, Seltzer JL: Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc Natl Acad Sci USA 94: 4424-4429, 1997
3. Seltzer JL, Lee AY, Akers KT, Sudbeck B, Southon EA, Wayner EA, Eisen AZ: Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 213: 365-374, 1994
4. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728-735, 1995
5. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7: 2062-2072, 1994
6. Wang Z, Juttermann R, Soloway PD: TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275: 26411-26415, 2000
7. Sternlicht MD, Werb Z: How matrix metalloproteases regulate cell behaviour. Annu Rev Cell Dev Biol 17: 463-516, 2001
8. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336, 1991
9. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling (review). Trends Genet 6: 121-125, 1990
10. Murphy G, Sellers A: In: D.E. Wolley, J.M. Evanson (eds). Collagenases in Normal and Pathological Connective Tissues. Wiley, New York, 1980, pp 65-81
11. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE: Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a 'cysteine switch' mechanism for activation. Proc Natl Acad Sci USA 87: 364-368, 1990
12. Van Wart HE, Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578-5582, 1990
13. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margullies IM, Liotta LA: The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264: 1353-1356, 1989
14. Moll UM, Youngleib GL, Rosinski KB, Quigley JP: Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT 1080 tumor cells. Cancer Res 50:6162-6170, 1990
15. Stefansson S, Aimes RT, Seward NB, Alexander DS, Quigley JP: Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts. J Cell Physiol 161: 419-428, 1994
16. Howard EW, Bullen EC, Banda MJ: Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13064-13069, 1991
17. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJP: The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 283: 637-641, 1992
18. Ward RV, Hembry RM, Reynolds JJ, Murphy G: The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 278: 179-187, 1991
19. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelam S, He CS: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207-8211, 1989
20. Chen JM, Aimes RT, Ward GR, Youngleib GL, Quigley JP: Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J Biol Chem 266: 5113-5121, 1991
21. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetler-Stevenson WG: Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 267: 15398-15405, 1992
22. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194: 721-730, 1990
23. Kolkenbrock H, Orgel D, Hecker-Kia A, Noack W, Ulbrich N: The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem 198: 775-781, 1991
24. 2+ release from pulmonary smooth muscle mitochondria. Moll Cell Biochem 159: 95-103, 1996
25. 2+ ATPase by tertiary butylhydroperoxide. Mol Cell Biochem 237: 85-93, 2002
26. Master BSS, Williams CH, Kamin H: The preparation and properties of microsomal TPNH cytocrhrome C reductase from pig liver. Meth Enzymol 10: 565-573, 1967
27. Wharton DC, Tzagoloff A: Cytochrome oxidase from beef heart mitochondria. In: Methods in Enzymology. Academic Press, New York, 1967, pp 10, 245, 249
28. Hodges TK, Leonard RT: Purification of a plasma membrane bound adenosin triphosphatase from plant roots. In: S. Fleischer, L. Packer (eds). Methods in Enzymology, 32, part B. Academic Press, New York, 1974, pp 396-397
29. Chen PS, Toribara TY, Warner H: Microdetermination of phosphorous. Anal Chem 28: 1756-1758, 1956
30. 2+-ATPase from rat cortex, cerebellum and hippocampus. Biochim Biopys Acta 1448: 99-108, 1998
31. Englard S, Scifter S: Precipitation techniques. Meth Enzymol 182: 285-300, 1990
32. Triebel S, Blaser J, Gote T, Pelz G, Schuren E, Schmitt M, Tschesche H: Evidence for the tissue unhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. Eur J Biochem 231: 714-719, 1995
33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophasge T4. Nature (Lond) 227: 680-685, 1970
34. Oakley BR, Kirsch DR, Morris NR: A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105: 361-363, 1980
35. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG: Cellular activation of the 72 kDa type IV procollagenase TIMP-2 complex. Kidney Int 43: 163-170, 1993
36. Billings PC, Haber JM, Liao DC, Tuttle SW: Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor. Cancer Res 51: 5539-5543, 1991
37. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76:4350-4354, 1979
38. Zhou H, Bernhard EJ, Fox FE, Billings PC: Induction of metalloproteinase activity in T-lymphocytes. Biochim Biophys Acta 1177: 174-178, 1993
39. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ: Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248: 265-268, 1987
40. Masui Y, Takemoto T, Sakakibara S, Hori H, Nagai Y: Synthetic substrates for vertebrate collagenase. Biochem Med 17: 215-221, 1977
41. David WW: In: Biostatistics: A foundation for analysis in health science. Wiley, New York, 1978, p 219
42. The lysosome concept: Ciba Symposiums on Lysosomes. In: A.V.S. de Reuck, M.P. Cameron (eds). Little, Brown, Boston, MA, 1963. pp 1-35
43. Ketis NV, Hoover RL, Karnovsky MJ: Isolation of bovine aortic endothelial cell plasma membranes: Identification of membrane associated cytoskeletal proteins. J Cell Physiol 128: 162-170, 1986
44. Clark ME, Lanz HC, Senior JR: Enzymatic distinction of rat intestinal cell brush border and endoplasmic reticular membranes. Biochem Biophys Acta 183: 233-238, 1969
45. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374-17378, 1989
46. Galis ZS, Kranzhofer R, Libby P: Thrombin promotes activation of matrix metalloproteinase-2 (MMP-2) produced by cultured smooth muscle cells. FASEB J 9: A413, 1995
47. Olson MW, Gervasi DC, Mobashery S, Fridman R: Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 272: 29975-29983, 1997
48. 2+ATPase activity under peroxynitrite treatment in pulmonary vascular smooth muscle plasma membrane. IUBMB Life 53: 167-173, 2002
49. -) in plasma membrane of bovine pulmonary vascular smooth muscle. Indian J Biochem Biophys 39: 390-396, 2002
50. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 98: 2572-2579, 1996
51. 2+ ATPase by hydrogen peroxide in pulmonary vascular smooth muscle plasma membrane. J Biosci 28: 205-213, 2003
52. Mellgren RL, Merieie MT, Lane RD: Proteolysis of the calcium dependent protease inhibitor by myocardial calcium-dependent protease. Arch Biochem Biophys 246: 233-239, 1986
53. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, Stamp A, Taylor G, Moran AM, Landis W, Langer R, Vacanti JP, Mayer JE: Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 68: 2298-2304, 1999
54. Frisdal E, Gest V, Vieillard-Baron A, Levame M, Lepetit H, Eddahibi S, Lafuma C, Harf A, Adnot S, Dortho MP: Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 18: 838-845, 2001
55. Yosef YB, Lahat N, Shapiro S, Bitterman H, Miller A: Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res 90: 784-791, 2002